Neuro-Oncology Section

The Neuro-oncology Section focuses on education, administration, research and patient care as it applies to neuro-oncology.

Lisa Roger's picture

Lisa Rogers, MD, DO

Chair

Dana Borror's picture

Dana Borror

Senior Specialist, Research, Education and Development
dborror@aan.com
(651) 332.8680

Neuro-Oncology Section News

2012 AAN Annual Meeting: It's YOUR Meeting. It's YOUR Experience.

Early registration discounts end March 28, 2012, and the housing deadline is March 21, 2012. (January 19, 2012)

Latest Test Your Knowledge Question Focuses on Patient with Primary CNS Lymphoma

FREE to AAN members, the popular Test Your Knowledge quiz is now available in mobile version on m.AAN.com! (August 19, 2011)

2012 Annual Meeting Education Program Proposals

The deadline to submit proposals for new education programs for the 2012 Annual Meeting in New Orleans, LA, is May 12, 2011. (April 5, 2011)

Neuro-oncology

UCNS Neuro-oncology Certification Examination Application Deadline, UCNS Neuro-oncology Accreditation Application Deadline (April 5, 2011)

UCNS Neuro-Oncology Accreditation Application Deadline

The accreditation application deadlines are as follows: July 1, for fall review, and December 31, for spring review. (April 5, 2011)

AAN Members Urged to Sign Up for Free Electronic FDA Patient Safety Alerts

The AAN and the Health Care Notification Network have teamed up to provide Academy members with free emails that deliver timely neurology-specific FDA-mandated patient safety drug alerts electronically. (April 5, 2011)

Important: Update Your Membership Contact Information Today

Update your contact information today to be sure your address and other contact information is current. (April 5, 2011)

Archives   |   RSS

Neuro-Oncology Community

Recent Articles

  • Teaching neuroimages: sequential MRI of the pituitary in Sheehan syndrome.
  • Teaching neuroimages: neuroradiologic findings in pontine and extrapontine myelinolysis: clue for the pathogenesis?

View the Neuro-Oncology community.